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Abstract
Introduction: The clinical value of double contrast-enhanced ultrasonography
(DCUS) in determining the Lauren classification of advanced gastric carcinoma
needed investigation.
Material and methods: Fifty-eight patients with gastric cancer proved by
endoscopic biopsy underwent preoperative DCUS examination in which an oral
contrast agent was combined with an intravenous agent, and the findings were
compared with the postoperative pathological findings using haematoxylin-
eosin and Alcian Blue-Periodic Acid Schiff (AB-PAS) staining. 
Results: Of 58 patients, 34 (59%) were the intestinal type and 24 (41%) the
diffuse type on pathological examination of resected specimens. Among
intestinal type patients, 30 (88%) showed homogeneous vascular enhancement
and 4 (12%) heterogeneous enhancement with the “sandwich” pattern in 
2 patients (50%) and “barrier” pattern in 2 patients (50%). In the diffuse type,
22 of 24 patients (92%) enhanced heterogeneously, with stippled and peripheral
enhancement in 9 (41%), the “sandwich” pattern in 8 (36%) and “barrier” pattern
in 5 (23%). Two of 24 patients (8%) with the diffuse type enhanced homo  -
geneously. The proportion of heterogeneous enhancement was significantly
different between the 2 subtypes of tumour (p = 0.0001). The sensitivity and
specificity of heterogeneous enhancement in diagnosing the diffuse type of
advanced gastric cancer were 92% and 88%, respectively. Youden’s index was 0.8.
Conclusions: Double contrast-enhanced ultrasonography is a new and useful
method to determine Lauren classification in patients with gastric carcinoma.
Key words: ultrasonography, microbubbles, contrast, gastric carcinoma, Lauren
classification.
Introduction
Gastric cancer is one of the most frequent causes of cancer-related
death in East Asia [1, 2]. Despite the recent advances in diagnostic
techniques for early detection and the improvement in surgical treatment,
gastric carcinoma remains the second most common cause of death from
cancer [3]. It is essential to predict precisely the risk of recurrence in order
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to minimize adverse effects and to maximize the
therapeutic effect in the treatment of cancer
patients. At least 4 different histological classi  fi  -
cation systems for gastric adenocarcinoma are in
common use (Goseki, Lauren, Ming, and the World
Health Organization (WHO) [4-7]. 
From an epidemiological standpoint, one helpful
method is the Lauren classification [8], which
divides gastric cancers into 4 histological types:
intestinal and diffuse, mixed, and unclassified. We
investigated the intestinal and diffuse types in our
study. Patients with the mixed and unclassified
types were not investigated because we did not
have these patients.
There are pronounced differences in pathology,
epidemiology, biological behaviour, and prognosis
between the intestinal and diffuse types. The
diffuse type has a worse prognosis [9]. Compared
with the WHO classification and Lauren clas  -
sification, Roukos reported that, in general, well and
moderately differentiated cancers according to the
WHO classification correspond to the intestinal type
of Lauren, whereas poorly or undifferentiated and
signet ring cell carcinomas correspond to the diffuse
type [10]. Different types of Lauren gastric
carcinoma have different biological behaviours [11-
13]. For the intestinal type, the macroscopic margins
correspond approximately to the microscopic extent
of the tumour. The diffuse type of a poorly dif  -
ferentiated cancer may extend submucosally far
beyond its macroscopic borders. This difference in
tumour spread is important for selecting the
appropriate treatment [14]. The Lauren classification
has proven useful in evaluating the natural history
of gastric carcinoma, especially with regard to
incidence trends, clinicopathological correlations,
and aetiological precursors [14]. Different types of
Lauren classification may have different biological
behaviours and prognosis. The choice of surgical
procedure in resectable gastric carcinoma is dictated
by size, location, and ability to achieve adequate
margins clear of disease. Other methods used to
diagnose and stage gastric carcinoma include
endoscopy, upper gastrointestinal barium computed
tomography, magnetic resonance imaging, ab  -
dominal ultrasound, positron emission tomo  graphy
scans, and staging laparoscopy.
The use of pathological features in addition to
the standard Lauren classification better separates
chronic cancers (survivors beyond 5 years after
diagnosis) from cured cancers and shows
differences in behaviour between histological types
[15]. The purpose of this study was to evaluate the
Lauren classification of patients with advanced
gastric cancer preoperatively using double contrast-
enhanced ultrasonography (DCUS) in which an oral
ultrasonic contrast agent is combined with an
intravenous contrast agent.
Material and methods
Seventy-nine patients with gastric cancer proven
by endoscopic biopsy were examined with DCUS
preoperatively. Of the 79 patients, 6 were excluded
because their tumours were unresectable and
another 15 because of the early stage of their
carcinomas. The remaining 58 patients were
enrolled in this study. The 58 patients included 
41 men and 17 women, mean age 54 ±18 years. 
All patients were studied in the second affiliated
hospital of Wenzhou Medical College in China.
Surgical resections were performed within 5 days
after the DCUS examination. None of the patients
received non-steroidal anti-inflammatory drugs,
chemotherapy, radiotherapy, or immunotherapy
before surgery.
Informed consent was obtained from all patients
prior to their examination. The local ethics
committee approved this study.
Double contrast-enhanced ultrasonography was
performed after fasting for at least 6 h [16].
Atropine sulfate (0.05 mg/kg) was administered by
intramuscular injection half an hour before the
examination to inhibit gastric peristalsis [16]. An
Acuson Sequoia 512 system (Siemens, Mountain
View, CA), equipped with a 4V1 vector™ transducer
(frequency: 1.0-4.0 MHz) and the microbubble-
specific contrast pulse sequencing (CPS) technology,
was used [17].
The oral contrast agent Xinzhang® (Huqingyu  -
tang, HangZhou, China) was supplied as a powder
which is derived from rice and soya (48 g per
package). It was reconstituted by adding 500 ml of
boiling water and gently agitating by hand to form
a palatable homogeneous suspension [16]. 
The distal oesophagus and the cardia of all
patients were studied in real time B-mode using
conventional tissue settings while the patients
ingested the oral agent to expand the stomach
and displace the air within it [16]. The lumen
appears as a mid-grey, homogeneous region that
acts as an acoustic window and improves
visualization of the inner wall (Figures 1A-B). Then
the rest of the stomach and the duodenal bulb
were examined in turn with the patient in the
supine and both decubitus positions to facilitate
complete filling and visualization of the stomach
wall. When a sus  pected lesion was identified, it
was measured routinely. For lesions less than
1.5 cm thick, write-zoom was used to improve
spatial resolution. 
Afterwards, dynamic real-time contrast-
enhanced sonography was performed with the CPS
mode at a transmit frequency of 1.5 MHz and a low
mechanical index (0.20), selected to minimize
microbubble disruption. Vascular contrast-enhanced
sonographic studies were performed after the
administration of 2.4 ml of SonoVue (Bracco SpA,
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Milan, Italy) as a bolus via a 19-gauge peripheral
intravenous cannula followed by a 10 ml saline
flush. A timer on the sonography unit was started
at the time of injection, and the entire movie
sequence (at least 5 min) was stored on magnetic
optical disks for analysis. The contrast study could
be repeated a second time if necessary.
The cine loops of the 58 lesions were retro  -
spectively reviewed by 3 independent radiologists
who are experts in sonography and microbubble
contrast agents. These 3 reviewers were unaware
of the final diagnosis and other imaging information
at the time of the analysis. 
Vascular enhancement of gastric carcinomas
was classified into 2 patterns: homogeneous
enhancement and heterogeneous enhancement.
Homogeneous enhancement was defined as an
even signal intensity over the whole tumour with
no signal defects during the early arterial phase
(lasting 25 seconds after injection) (Figures 2A-D).
Heterogeneous enhancement was defined as an
uneven signal intensity over the lesion during the
early arterial phase with stippled and peripheral
enhancement (Figures 3A-D). In the “sandwich”
pattern, the enhancement took the form of layers
in the tumour (Figures 4A-B). In the “barrier”
pattern, the enhancement began at the serosa and
progressed to the mucosa (Figures 5A-B).
Agreement regarding the classification of all lesions
was reached by consensus. 
The surgically resected specimens were
immediately fixed in 85% ethanol and embedded
in paraffin. Ten to 15 pieces of tumour tissue were
obtained from each sample, dehydrated routinely
with graded ethanol, embedded in paraffin, and cut
into 4-m thick sections. For each block, 2 slides were
prepared, one stained with haematoxylin and eosin
(H&E) for pathological diagnosis and the other one
stained for histochemical analysis. Haematoxylin
and eosin and alcian blue (pH 2.5) - periodic acid
Schiff (AB-PAS) staining were performed [18]. 
Briefly, for AB-PAS staining, the paraffin slides
were deparaffinized with xylene. One hundred
microlitres of AB staining solution (Fluka Company)
was added to the slides for staining in wet boxes
for 20-30 min and washed with distilled water for
3-5 min. One hundred ml of 0.5% periodic acid
solution was applied for oxidation for 10 min and
washed with distilled water for 3-5 min. Staining
was performed with Schiff solution for 10 min. The
slides were then washed with distilled water for 
5-10 min. Finally, the slides were sealed with neutral
gum. The tumours were classified according to
Lauren’s description [8] as intestinal (Figure 2A-D) or
diffuse (Figure 3A-D).
SPSS version 12.0 (SPSS Inc. Chicago, USA) was
used for the statistical analysis. Numerical data
were compared using χ2 test between the 2 sub  -
types of tumour. Sensitivity, specificity, and
Youden’s index were calculated. Youden’s index is
the sum of the sensitivity and specificity (expressed
as fractions) minus one. For all analyses, a p value
of less than 0.05 was considered statistically
significant. 
Results
Among the 58 patients included in the study, 
34 (59%) were histologically diagnosed as the
intestinal type and 24 (41%) as the diffuse type.
Thirty of the 34 patients (88%) with the intestinal
type showed global and homogeneous enhan  -
cement. Four of the 34 patients (12%) showed
heterogeneous enhancement with the “sandwich”
pattern in 2 patients (50%) and the “barrier”
pattern in 2 patients (50%). Among the 24 patients
with diffuse lesions, 22 (92%) enhanced
heterogeneously, with stippled and peripheral
Figure 1. The effect of the oral contrast agent. A) Following swallowing of the Xinzhang® oral contrast agent, 
the gastric lumen appears as a mid-grey, homogeneous region that acts as an acoustic window and improves
visualization of the inner wall (arrows). This was a normal patient. B) In another patient, a gastric carcinoma is
clearly displayed as a hypoechogenic region (between two cursors) after taking the Xinzhang® oral contrast agent
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enhancement in 9 patients (41%), the “sandwich”
pattern in 8 patients (36%), and the “barrier”
pattern in 5 patients (23%). The remaining 2 diffuse
cases enhanced homogeneously. Final tumour
staging according to the gold standard was 
0 patients at stage T1, 22 patients at stage T2, 
30 patients at stage T3, and 6 patients at stage T4.
Chi-square analysis showed that the proportion
of heterogeneous enhancement was significantly
different between the 2 subtypes of tumour 
(p = 0.0001). Taking heterogeneous enhancement
as a criterion for the diffuse type of advanced
gastric cancer, the sensitivity and specificity were
92% and 88% respectively (Table I). Youden’s index
was 0.8. The κ value of this method was 0.75.
Discussion
In 1965, Lauren reported a histological
classification in which gastric carcinomas were
divided into intestinal and diffuse types. The
intestinal type of gastric carcinoma is histologically
characterised by the presence of cohesive cells
forming glandular and papillary structures and acidic
mucous as judged by Alcian blue pH 2.5)/periodic
acid Schiff staining of mucous. The diffuse type of
gastric carcinoma is characterized histologically by
non-cohesive cells, the common presence of signet
ring cells, and neutral mucous as judged by high iron
diamine/Alcian blue pH 2.5 staining. The intestinal
type is more common in men, typically arises in the
antrum, and has a better prognosis. The diffuse type
is only slightly more common in men and also
occurs in younger patients. It generally arises in the
fundus and is associated with blood group A.
Regional and ethnic group variations in gastric
carcinoma incidence appear to be related to the
prevalent histological type [19, 20]. The intestinal
type predominates in epidemic zones such as the
Far East [21]. When gastric carcinoma incidence
declines, as it has in Europe and the United States,
it has been predominantly the intestinal type that
has diminished in frequency. The incidence of the
diffuse type has remained unchanged or has
decreased to a much lesser degree [19, 22-24].
Because the incidence of intestinal type cancer can
change dramatically over a relatively short period, it
has been hypothesized that its pathogenesis may
be linked to environmental and socioeconomic
factors. Additional support for the environmental
hypothesis comes from studies of migrants, which
A B
C D
Figure 2. Intestinal type of gastric carcinoma. A) The tumour is displayed as a hypoechoic mass (between two cursors)
after taking the Xinzhang® oral contrast agent. B) This tumour enhanced homogeneously with no signal defects
during the early arterial phase (white arrow). C) The tumour proved to be a well differentiated intestinal type of
carcinoma (×200 HE). D) On AB-PAS staining, the acid mucus took up the blue dye (×200)
STO – stomach
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Figure 3. Diffuse type of gastric carcinoma. A) In another patient, a gastric carcinoma was again clearly displayed
(between two cursors) as an echo-poor region after taking the Xinzhang® oral contrast agent. B) The tumour enhanced
heterogeneously during the early arterial phase with stippled and peripheral enhancement (white arrows). C) This
carcinoma was poorly differentiated; the blue arrows show the signet-ring cells (×200 HE). D) AB-PAS staining shows
the neutral mucus (×200)
Figure 4. Diffuse type of gastric carcinoma showing the sandwich pattern. A) The oral contrast agent highlights the
hypoechogenic tumour (between the cursors). B) During the early arterial phase of i.v. enhancement the tumour
enhanced hetero  geneously with the sandwich pattern (white arrows)
AB
demonstrate retention of parent-country risk in first
generation migrants but not in later generations [25]. 
In contrast, diffuse type disease is thought to be
largely genetic in aetiology. The intestinal type is
characterized by cohesive neoplastic cells forming
gland-like tubular structures, whereas in the diffuse
type cell cohesion is absent so that individual cells
infiltrate and thicken the stomach wall without
forming a discrete mass. This difference in
microscopic growth pattern is also reflected in the
different macroscopic appearance of the 2 histo  -
logical subtypes. [5]. The development of the292 Arch Med Sci 2, April / 2011
intestinal type of gastric cancer is a progression of
mucosal changes from superficial gastritis to
chronic atrophic gastritis and metaplasia before
malignancy appears [26, 27].
While there are many reports on the preoperative
staging of gastric carcinoma using multidetector
computed tomography with high accuracy [28-31],
few reports have been reported on the preoperative
Lauren classification of gastric carcinoma using
imaging modalities [32, 33]. It is very difficult for
conventional ultrasound to visualize gastric cancers
because stomach gas interferes with imaging. The
use of an oral contrast agent improves their
detection [34].
Intravenous contrast-enhanced ultrasonography
has been widely used to assess tumours in vivo.
Double contrast-enhanced ultrasonography has
been reported as a valid method to evaluate the
microcirculatory perfusion of gastric carcinomas
[34]. In this study, we sought to identify whether
DCUS could be used to evaluate Lauren’s his  -
tological classification of gastric carcinomas.
The intestinal type of gastric carcinoma accounts
for approximately 50% of gastric carcinomas and the
diffuse type for 35%. The remaining 15% of gastric
carcinomas are unclassified or mixed type carcinomas
[5, 24, 35, 36]. Among our 58 patients, 34 (59%) were
diagnosed as the intestinal type and 24 (41%) as the
diffuse type. None of our patients had an unclassified
or mixed type gastric carcinoma on pathological
examination of the resected specimens. 
The characteristics of gastric carcinoma DCUS
examination correlated closely with the Lauren
classification. Among 34 patients with the intestinal
type, 30 lesions (88%) showed homogeneous
enhancement after intravenous contrast injection.
In 24 patients with the diffuse type, 22 lesions
(92%) had heterogeneous enhancement. Therefore,
homogeneous vascular enhancement could form
a useful diagnostic criterion for the intestinal type
of gastric cancer and heterogeneous enhancement
for the diffuse type. 
The sensitivity and specificity of the pattern of
heterogeneous vascular enhancement on DCUS to
detect the diffuse type of gastric cancer were 92%
and 88%, respectively. Youden’s index of DCUS to
predict the Lauren classification was 0.8. However,
there were 4 patients (12%) with the intestinal type
that enhanced in heterogeneous patterns, and 
2 patients (8%) with the diffuse type that enhanced
homogeneously.
In conclusion, DCUS shows promise as a new
noninvasive, convenient method to distinguish the
histological classification of gastric carcinoma and
may have a role in evaluating the prognosis in
patients with gastric carcinoma in vivo.
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DCUS Lauren classification
Diffuse type Intestinal type
Heterogeneous 22 4
enhancement
Homogeneous 2 30
enhancement
Table I. Evaluation of Lauren classification for gastric
carcinoma using double contrast-enhanced ultra  -
sonography (DCUS)
The proportion of heterogeneous enhancement was significantly
different between the diffuse and intestinal types of gastric carcinoma
(p = 0.0001). The sensitivity and specificity of heterogeneous
enhancement in diagnosing the diffuse type of gastric carcinoma were
92% and 88%, respectively. Youden’s index was 0.8
Figure 5. Diffuse type of gastric carcinoma showing the barrier pattern. A) The echopoor gastric carcinoma is clearly
displayed (white arrows) using oral contrast ultrasonography. B) This lesion of the diffuse type enhanced
heterogeneously during the early arterial phase with the barrier pattern (white arrows)
STO – stomach
AB
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